• No results found

Symptom Management in MS. Nancy Fontneau MD Department of Neurology University of Massachusetts

N/A
N/A
Protected

Academic year: 2021

Share "Symptom Management in MS. Nancy Fontneau MD Department of Neurology University of Massachusetts"

Copied!
38
0
0

Loading.... (view fulltext now)

Full text

(1)

Symptom Management in MS

Nancy Fontneau MD

Department of Neurology

(2)

Disclosures

I have nothing to disclose

I will discuss off label use of some

(3)

Overview

Management of Symptoms in MS

makes quality of life better for our

patients.

Problems vary from patient to

patient and time to time.

Anticipatory patient education helps

(4)

Topics

Weakness and Spasticity

Fatigue

Urinary Dysfunction and

Incontinence

Bowel Dysfunction

Sexual Dysfunction

(5)

Weakness and Mobility

Usually legs worse than arms

Mobility dysfunction in > 70% of patients

General conditioning as well as specific

exercise of weakened muscles helps

Rest periods and avoidance of

overheating is needed

Adaptive aids for walking and ADLs may

help patients maintain independence

(6)

Fatigue

Common in MS patients

May occur when little energy used

Often worse following activity or at

end of day

May bring out deficits not present

when refreshed (foot drop, blurry

vision, etc)

Limits social and occupational

(7)

Managing Fatigue

Educate re energy conservation

techniques and equipment

Optimize nocturnal sleep. Plan rest

periods before important activities

Avoid hot environments

Medications

 Stimulants (methylphenydate, amphetamines)  Provigil

 Antidepressants (especially activating ones)  Amantadine

(8)

Spasticity

It is velocity dependent muscle over

activity that results from injury to nerves

in the brain and spinal cord. It is one of

the most common problems in MS.

It can have symptoms of stiffness,

inability to move one muscle

independently of another, and spasms

(may be painful).

Can limit walking, transfers, sitting,

(9)

Not all spasticity is Bad!

When patients are weak, spasticity

may allow weight bearing for

transfers or even walking.

Spasms can help move a patient to

(10)

What makes spasticity worse?

An MS attack may make spasticity worse

(or may lessen it if there is “shock” or

increased weakness).

An infection (like a UTI or the flu)

Constipation, full bladder, menstrual

periods

Pain

Skin sores

Extremes of heat or cold

Help your patient get to know what

makes their spasticity worse. Its

individual.

(11)

Managing Spasticity

Partnership between patient and MD

How physicians can help….

 Prescribe medications

 Prescribe PT, OT, braces, splints

 Recommend nerve blocks or other treatments  Make sure there are no contractures or

decubiti

What patients can do…..

 Know their triggers—avoid them if possible  Do stretching program faithfully

 Take medications as instructed

(12)

Medications for Spasticity—1

Dose must be slowly increased for

each patient to optimize good

effects and reduce side effects.

Most are 3-4 times/d.

All have similar side effects—

drowsiness, weakness when too

much is given. Some cause dry

mouth or low blood pressure.

Some forms can be used together.

Most should not be stopped

suddenly!!!! Please warn your

patients.

(13)

Medications for Spasticity--2

 Baclofen (Lioresal®) agonist at spinal cord GABA

receptor. It can be given orally or directly into the spinal space with an implanted pump. This route reduces drowsiness, but works much better for leg than arm spasticity.

 Tizanidine (Zanaflex®), an alpha blocker, works

centrally to relax muscles.

 Diazepam (Valium®) works in the entire nervous

system to relax muscles, at GABA receptors. It also decreases anxiety and promotes sleep.

Patients may withdraw with quick discontinuation. Clonazepam (Klonopin®) is similar.

(14)

Medications for Spasticity—3

 Dantrolene (Dantrium®) works directly on the Ca

channels in muscles. Side effects on liver, so LFTs needed to monitor.

 BOTOX® or other botulinum toxins (Myobloc®,

Dysport®) is injected into muscles when spasticity is focal.

 Phenol or Alcohol Nerve blocks may be used when

the motor nerves can be isolated, to weaken spastic muscles. They last longer then BOTOX. Best for adductors of hips (obturator nerve).

 Pain treatment, when appropriate, can also

(15)

Surgery for Spasticity

Surgery is needed to place the

Intrathecal Baclofen Pump

Tendonotomy--Surgery to cut or

lengthen tendons, can restore

mobility to a joint.

Rhizotomy—Surgery to cut nerve

roots in the spinal cord to relax

muscles nearby.

(16)
(17)

Stretches

Should be

individualized to

patient need

Help

maintain/regain

joint range of

motion and avoid

contractures.

Should be done

daily, with other

treatments

(18)

Physical and Occupational Therapy

Physical Therapy—Teach positioning

to reduce spasticity, stretching and

strength home exercise programs,

use of heat or ice, massage, splints

or braces.

Occupational Therapy—Teach

adaptive equipment to maximize

independence, positioning and

seating in wheelchair, upper

(19)

Bracing and Splints

Braces work to support joints, reduce

injury, assist weakened muscles.

Splinting supports joints to prevent or

reduce contractures.

Patients need to wear them!!

 Cosmetics and fit are important, as well as

function

 May need larger shoe. Should remove

innersole from shoe with brace. Look for shoe with big toe box and flat sole (walking shoe or cross trainer, not running style)

(20)

Choice of Braces

Toe off AFO—

 for foot drop, little spasticity or inversion

Solid ankle AFO—

 For foot drop (MRC 2-3 Tib Ant), knee

hyperextension or buckling, poor endurance, poor proprioception, mild spasticity

Articulated ankle AFO

 For more natural movement at ankle, allows

driving or squatting in brace, allows adjustment of dorsiflexion

Double metal upright AFO—

(21)
(22)

Walk Aide

Functional

Electrical

Stimulation to

Peroneal nerve for

foot drop

(23)
(24)
(25)
(26)

Urinary Dysfunction

Almost all MS patients will develop

Two main types—

 Urge incontinence—patient has insufficient

time to get to toilet before voiding reflex begins.

 Detrusor-sphincter dyssynergia—patient gets

urge but cannot initiate, or initiation slow and voiding incomplete.

UTI and decubiti and falls can result from

UI

(27)

Urinary Dysfunction--2

Normal voiding reflex contracts

detrusor at same time that

sphincters (internal and external)

relax

Parasympathetics Pee and

Sympathetics Squeeze and Store.

Up to 8 voids/day and 2/night is

normal. Nocturia may contribute to

fatigue in MS

(28)

Medications For Urinary Dysfunction

To increase storage:

 Anticholinergics (propantheline, hyoscyamine,

solifenacin, fesoterodine, darifenacin)

 Smooth muscle relaxers (oxybutynin,

flavoxate, dicyclomine)

 Tricyclic antidepressants (imipramine, doxepin)  Treat spasticity

To improve sphincter opening:

 Alpha blockers (terazosin, prazosin, clonidine)  Tamsulosin

(29)

Other options for urinary problems

Catheters

 Self intermittent catheterization (or by helper)  Indwelling Foley

Surgical solutions

 Suprapubic catheter  Urinary diversion

 Sphincterotomy (with condom cath for men)

DDAVP if nocturia prevents sleep

Absorptive pads, timed voiding

(30)

Bowel Dysfunction

Presents in a majority of MS patients at

some point.

Most commonly constipation—MS rarely

causes hyperactive bowels or rectal

sensory loss leading to incontinence.

Most patients should be able to achieve

continence with good management.

Important for skin integrity but most

important for social interactions

Constipation also leads to bladder

(31)

Bowel Dysfunction-2

Mechanisms:

 Diminished bowel motility from SC lesion  Overall diminished mobility worsens

constipation, especially if patient cannot use commode for elimination. Abdominal muscle weakness makes defecation more difficult.

 Poor dietary habits (low fiber)

 Poor fluid intake (to reduce bladder accidents)  Side effects of medications (particularly

anticholinergics for bladder and antidepressants)

(32)

Bowel Management

 Goals—regular elimination pattern with good

evacuation and no stool oozing

 Methods

 Adequate fluid and fiber intake (dietary fiber, psyllium, methylcellulose, polycarbophil)

 Softeners and fiber help hold more water in stool

 Laxatives—osmotic (lactulose, MOM, Mag Citrate, PEG)  Laxatives—stimulant (Senna, bisacodyl)

 Time toileting for 20-30 minutes after meal—uses gastrocolic reflex to help peristalsis.

 Suppositories, Enemeez®, digital stimulation may start reflex defecation.

 Allow sufficient uninterrupted time for elimination

(33)

Sexual dysfunction in MS

 Frequent, and often associated with bladder and

bowel problems.

 Both sexes experience low libido, decreased

genital sensation, alteration of experience of orgasm and fatigue from MS

 Men have difficulty with getting or maintaining

erection and with ejaculation.

 Women have difficulty with arousal and

lubrication

 Non-genital physical and psychological imitations

may also affect ability to engage in sexual activity.

(34)

Sexual Dysfunction—first steps

Open a discussion, give permission

to talk, normalize the experience for

the patient

RELAX yourself--try to speak with

both partners together

Get the history—find out the

problems and whether the partners

need information

(35)

Sexuality--Specific Suggestions

 Timing—when fatigue is minimal, bowels and bladder

evacuated (if an issue)

 Positioning for comfort and physical abilities  Water soluble lubricant

 Dealing with catheters

 Dealing with erectile dysfunction

 Medications (Sildenafil, Tadalafil, Vardenafil, alprostadil)  Vacuum pump

 Penile protheses (surgical)

 Dealing with arousal problems

 vibrators, direct genital stimulation by mouth or hand

 Give permission to experiment  Fertility

(36)

Paroxysmal Symptoms

Painful spasms (usually flexor)—

Carbamazepine, gabapentin, PTN

Trigeminal Neuralgia—

Carbamazepine, PTN, Baclofen,

Gabapentin, Amitryptiline

(37)
(38)

References

Related documents

Approximately 10 min after the HIFU treatment, the capsules were con- trolled using the same T1- and T2-weighted pulse se- quences as described in the first paragraph of the section

Portland State University  School of Business Administration  Masters of Taxation Proposal  Analysis of Demand   

In order to analyze and study the fuzzy control model of smart city optimization control, this paper designs a fully networked fuzzy controller based on BP neural network arithmetic,

(2004), and Lopez and Papell (2007) employed either panel or univariate, augmented, Dickey-Fuller (ADF) unit root tests to examine the stationarity of RERs for 23

investigated the impact of LDL status, sex, grade, and race on bullying victimization utilizing the 2015 and 2017 data from the national Youth Risk Behavior Survey.. These

Design: Comparison of 4 manual supine strength grades with isometric hip extension joint torque; ␬ statistic–deter- mined interrater reliability, and analyses of variance

A number of undesirable neurocognitive states (mind wandering, effort withdrawal, perseveration, inattentional phenomena) are identified and mapped within a two- dimensional

To evaluate the quality of the aggregated contributions we utilize the following metrics, commonly applied to measure the performance of machine learning and information